Cardiovascular

This multicenter study sheds more light on sex-based differences in aortic stenosis (AS) and argues the benefits of using cardiovascular magnetic resonance (CMR) to assess sex-based risks in AS.

February 18th 2025

HeartSense's Mission to Reveal, Combat Hidden CV Burdens in Underserved Communities

Kyle Munz Antoine Keller, MD, FACC, FACS

Antoine Keller, MD, founded HeartSense with the purpose of uncovering and addressing the cardiovascular needs of rural, often underserved communities.

Heart health. | Image Credit: udra11 - stock.adobe.com

February 14th 2025

5 Things That Impact Heart Health

Cameron Santoro

To maintain a healthy heart, researchers say people should focus on diet and exercise, limit alcohol, manage stress, get enough sleep, and more.

February 11th 2025

Abelacimab Shows Potential to Shift the Standard of Care in AFib

Kyle Munz Christian Ruff, MD Dan Bloomfield, MD

Results from the AZALEA-TIMI 71 phase 2 trial showed great promise for abelacimab to transform care for high-risk patients with atrial fibrillation.

February 6th 2025

Dr Ruff Explores Mitigating Surgical Bleeding in AFib With Abelacimab

Kyle Munz Christian Ruff, MD

Favorable bleeding outcomes related to abelacimab have positioned the medication as a potential game changer in the treatment of atrial fibrillation.

Conceptualizing reduced cost and increased value | image credit: patpitchaya - stock.adobe.com

February 3rd 2025

Polypill Treatment: A Clinically Effective and Cost-Saving Strategy for CVD Management

A polypill for preventing cardiovascular disease has the potential to address health inequities and expand health care access for low-income populations.

FDA approval | image credit: Aquir - stock.adobe.com

January 28th 2025

FDA Expands Semaglutide Use for CV, Kidney Risks in T2D, CKD

The latest semaglutide (Ozempic; Novo Nordisk) approval is set to tackle a major need for patients with both type 2 diabetes (T2D) and chronic kidney disease (CKD), addressing their cardiovascular (CV) and kidney disease risks.

Glass of sugar cubes | Image Credit: © grzejnik1981-stock.adobe.com

January 28th 2025

Curbing Sugary Beverages for Health and Economic Gains

Maggie L. Shaw

According to the CDC, frequent consumption of sugary drinks is linked to adverse health outcomes that include obesity, type 2 diabetes, heart disease, nonalcoholic liver disease, and gout.

Atrial fibrillation | image credit: Uladzlislau - stock.adobe.com

January 22nd 2025

Abelacimab, a “Game Changer” for High-Risk Patients With AFib: Dr Ruff and Dr Bloomfield Elaborate on Latest Data From AZALEA-TIMI 71 Trial

Kyle Munz Christian Ruff, MD Dan Bloomfield, MD

Clinically significant reductions in bleeding underscore abelacimab’s strong potential to address an unmet need for patients with atrial fibrillation (AFib).

Breast cancer awareness graphic | image credit: ST.art - stock.adobe.com

January 15th 2025

Breast Cancer Stage May Influence Risk of Prevalent CVD

Patient outcomes appeared to be more heavily driven by breast cancer stage than delays in diagnosis, researchers found.

January 14th 2025

Economic Data Show Cost-Effectiveness of Statin, Antihypertensive Polypill for CVD in Low-Income Populations

Giuliana Grossi

The health equity impact of the polypill is significant; by effectively controlling cardiovascular disease (CVD) risk factors in populations with limited health care access, there's potential to reduce income- and race-related health disparities.

Coffee | Image credit: dimakp - stock.adobe.com

January 9th 2025

Lower Risk of Cardiovascular Disease Mortality Associated With Morning Coffee

Julia Bonavitacola

Americans who drank coffee in the morning had a lower overall mortality compared with those who drank coffee later in the day.

Keith Ferdinand, MD, professor of medicine and the Gerald S. Berenson Chair in Preventative Cardiology, Tulane University School of Medicine

January 7th 2025

CKM Treatment Involves a Team-Based Approach, Says Dr Keith Ferdinand

Keith Ferdinand, MD, professor of medicine, Gerald S. Berenson Chair in Preventative Cardiology, Tulane University School of Medicine, continues his discussion on treatment approaches for patients with cardiovascular-kidney-metabolic (CKM) syndrome.

Cardiovascular top 5 of 2024 | Image Credit: Venngage

December 25th 2024

Top 5 Most-Read Cardiovascular Content of 2024

This year's top 5 most-read cardiovascular articles explored topics ranging from FDA approvals to the risks associated with the sugar alcohol xylitol and beyond.

Keith Ferdinand, MD, professor of medicine, Gerald S. Berenson chair in preventative cardiology, Tulane University School of Medicine

December 20th 2024

Tackling CKM Syndrome as a Holistic Approach to a Growing Health Crisis

Keith Ferdinand, MD, professor of medicine, Gerald S. Berenson Chair in Preventative Cardiology, Tulane University School of Medicine, discusses the interconnected condition of cardiovascular-kidney-metabolic (CKM) syndrome, which includes obesity, diabetes, chronic kidney disease, and cardiovascular disease.

December 20th 2024

ICYMI: AHA 2024 Scientific Session Highlights

Our top content from the 100th annual American Heart Association (AHA) Scientific Sessions included exclusive expert insights and highlighted promising treatments.

Heart pulse, beat concept in atrial fibrillation | image credit: martialred - stock.adobe.com

December 19th 2024

Q&A: Dr Dan Bloomfield Elaborates on Novel Findings From AZALEA-TIMI 71 Trial, Future of FXI Inhibitor Abelacimab

Dan Bloomfield, MD, chief medical officer, Anthos, walks through promising findings demonstrating the efficacy of abelacimab, a factor XI (FXI) inhibitor, to reduce bleeding risk in atrial fibrillation treatment.

ASCVD | Image credit: Zhanna - stock.adobe.com

December 17th 2024

Low Lp(a) Testing in ASCVD: Higher Levels in Black and Female Patients

Study identifies underutilization of testing, with disparities by race and sex.

December 11th 2024

Impact of Delayed Adoption of Novel Atrial Fibrillation Treatments

Jaehong Kim, PhD Jeremy Nighohossian, PhD Anastasia G. Daifotis, MD Jinghua He, PhD Jason Shafrin, PhD

Using direct oral anticoagulants as a case study, the authors examined how delayed adoption of novel treatments could impact patient health outcomes and cost.

Highlights from ASPC Congress 2024 | Image Credit: venngage.com

December 9th 2024

ICYMI: Highlights From ASPC Congress 2024

The top 5 most-viewed content from this year's American Society for Preventive Cardiology (ASPC) Congress on Cardiovascular Disease (CVD) Prevention included interviews with Robert Kushner, MD, MS, and Martha Gulati, MD, MS, FACC, FAHA, FASPC, FESC, as well as coverage on multiple areas of cardiovascular medicine.

EKG heartbeat line | Image Credit: Jiva Core - stock.adobe.com

December 6th 2024

Acoramidis Sustains Benefits in Patients With ATTR-CM in Open-Label Extension Study

Data presented at the 2024 American Heart Association (AHA) Scientific Sessions showed that continuous treatment with acoramidis (Attruby; BridgeBio Pharma) significantly reduced the risk of all-cause mortality (ACM) and cardiovascular-related hospitalizations (CVH) in patients with transthyretin amyloid cardiomyopathy (ATTR-CM).

Atrial fibrillation | Image credit: ibreakstock - stock.adobe.com

December 5th 2024

Lifestyle Changes Ease AFib Symptoms but Don't Lower Burden vs Standard Care

Metformin and lifestyle changes show no significant impact on atrial fibrillation (AFib) burden or progression compared with standard care.

FDA headquarters | Image Credit: Grandbrothers - stock.adobe.com

November 25th 2024

FDA Approves Acoramidis for ATTR-CM

Patrick Campbell

With approval, acoramaidis (Attruby; BridgeBio Pharma) becomes the first agent with a label specifying near-complete stabilization of transthyretin (TTR).

Cardiovascular health | Image Credit: BillionPhotos.com - stock.adobe.com

November 25th 2024

Unfavorable Health-Related Social Needs Associated With Lower Cardiovascular Health Scores

Adults with more unfavorable health-related social needs, such as unemployment or food insecurity, had a higher prevalence of low cardiovascular health, highlighting the importance of addressing social determinants to improve population health.

Heart examination | Image credit: Ngampol - stock.adobe.com

November 20th 2024

Elevated Stress Hyperglycemia Ratio Linked to Higher All-Cause Mortality After Cardiovascular Events

Evidence highlights the predictive value of the stress hyperglycemia ratio for mortality risk in patients with acute myocardial infarction, ischemic stroke, and acute heart failure.

Smoking health risk | Image credit: sorapop - stock.adobe.com

November 15th 2024

How Smoking Cessation Affects Cardiovascular Disease Risk Over Time

New study findings reveal that the risk of cardiovascular disease among light ex-smokers aligns quickly with never-smokers, while heavy ex-smokers may take over 25 years to reach the same level.

Stressed female employee | Image Credit: Charlie's - stock.adobe.com

November 6th 2024

A new study has linked work-related stress to poorer cardiovascular health, highlighting the need for workplace wellness programs to reduce the risk of cardiovascular disease.

Doctor holding heart_Pana Studio - stock.adobe.com.jpeg

October 24th 2024

Evaluating the American Heart Association’s PREVENT Equations: Enhancing CVD Risk Prediction

A new study assesses the prognostic accuracy of Predicting Risk of CVD EVENTs (PREVENT) equations for predicting cardiovascular disease (CVD) mortality in the US population.

October 19th 2024

Fostering Interdisciplinary Communication: How Cardio-Renal-Metabolic Care Models Optimize Care Delivery

Viet Le, PA-C, Intermountain Health, gives insights into the benefits cardio-renal-metabolic care models provide for patients in need.

"acute coronary syndrome" written on tablet | Image Credit: ibreakstock - stock.adobe.com

October 16th 2024

CHEST 2024 Posters Reveal Disparities in Acute Coronary Syndrome Care, Outcomes